Attovia Therapeutics is a biopharmaceutical company developing treatments for immune-mediated diseases using its proprietary ATTOBODY platform.

Imbria Pharmaceuticals, Inc. is a biotechnology company developing therapies for cardiometabolic diseases, focusing on advancing their lead product candidate for non-obstructive hypertrophic cardiomyopathy.

Latigo Biotherapeutics develops non-opioid pain treatments, focusing on selective Nav1.8 inhibitors.

Maze Therapeutics is a biopharmaceutical company focused on developing precision medicines for renal and metabolic diseases using human genetics.

Avenzo Therapeutics is a biotechnology company developing oncology therapies, including a CDK2 inhibitor for advanced solid tumors and HR+/HER2-negative metastatic breast cancer.

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.

Triveni Bio is a biotech company developing novel antibody treatments for immunological and inflammatory disorders.

Mariana Oncology is a biotechnology company that develops targeted peptide-based radiopharmaceuticals for the treatment of cancer, with a focus on delivering optimized radiation doses to solid tumors.